Gary Anthony Pestano - 08 Feb 2023 Form 4 Insider Report for BIODESIX INC (BDSX)

Role: Chief Development Officer
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for Gary Pestano
Issuer symbol: BDSX
Transactions as of: 08 Feb 2023
Net transactions value: -$3,332
Form type: 4
Filing time: 10 Feb 2023, 17:40:48 UTC
Previous filing: 10 Nov 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDSX	Common Stock	Options Exercise		+5,053	+5.4%		97,785	08 Feb 2023	Direct	F1
transaction	BDSX	Common Stock	Sale	$3,332	-1,852	-1.9%	$1.80	95,933	09 Feb 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDSX	Restricted Stock Units	Award	$0	+113,021		$0.000000	113,021	08 Feb 2023	Common Stock	113,021		Direct	F1, F4
transaction	BDSX	Restricted Stock Units	Options Exercise	$0	-1,378	-7.7%	$0.000000	16,539	08 Feb 2023	Common Stock	1,378		Direct	F1, F5
transaction	BDSX	Restricted Stock Units	Options Exercise	$0	-3,675	-33%	$0.000000	7,351	08 Feb 2023	Common Stock	3,675		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock.
F2	These shares of Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.
F3	The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F5	These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F6	These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.